Related Experiment Video
Updated: Apr 4, 2026

Author Spotlight: Assessing the Potential of Circulating Tumor Cells in Leptomeningeal Disease Research
Published on: March 29, 2024
MEGALENCEPHALIC LEUKOENCEPHALOPATHY WITH SUBCORTICAL CYSTS WITH HOMOZYGOUS MUTATION (C.448DELC, P.LEU150 SER FSX11)
Abstract:
MLC or Van der Knaap disease is a rare entity, a rare and genetically heterogeneous cerebral white matter disease. It is characterized by the presence of macrocephaly, epilepsy and a slowly progressive spastic cerebellar syndrome. It is an autosomal recessive disease caused from mutations of MLC1 gene. In the current case report, a case with MLC who had a homozygous mutation (c.448delC, p.Leul50 ser fsX11) on exon 6 of MLC1 gene is presented.
Insights
Van der Knaap disease (MLC) is a rare white matter disorder. This case report details a patient with a specific homozygous mutation in the MLC1 gene, contributing to understanding this genetic condition.
Area of Science:
- Neurology
- Genetics
- Molecular Biology
Background:
- Van der Knaap disease, also known as macrocephaly with progressive կspastic pseudobulbar syndrome, is a rare, genetically heterogeneous cerebral white matter disease.
- It is characterized by macrocephaly, epilepsy, and a slowly progressive spastic cerebellar syndrome.
- The condition is inherited in an autosomal recessive pattern, typically caused by mutations in the MLC1 gene.
Observation:
- This report presents a case of Van der Knaap disease.
- The patient exhibited a homozygous mutation (c.448delC, p.Leul50 ser fsX11) in exon 6 of the MLC1 gene.
Findings:
- Identification of a specific homozygous mutation in the MLC1 gene in a patient with Van der Knaap disease.
- This finding reinforces the role of MLC1 gene mutations in the etiology of this rare neurological disorder.
Implications:
- Contributes to the genetic understanding of Van der Knaap disease.
- May aid in the diagnosis and genetic counseling for families affected by this rare cerebral white matter disease.
- Highlights the importance of molecular genetic testing in diagnosing rare neurological conditions.
More Related Videos
07:45An In Vitro Model for the Study of Cellular Pathophysiology in Globoid Cell Leukodystrophy
Published on: October 21, 2014
08:56Modeling Mitochondrial Disease Using Brain Organoids: A Focus on Mitochondrial Encephalomyopathy, Lactic Acidosis, and Stroke-like Episodes
Published on: October 10, 2025
Related Concept Videos
Lysosomal Hydrolases
Cytomegalovirus Disease